Four COVID-death peaks:The COVID death toll in US reached one million last week, marking the total failure of US anti-epidemic policies. According to statistics, there were four peaks of daily new death cases since February 2020. How did the US policy fail so badly?
WHO okayed vaccines including CanSinoBIO jab
Geneva: The World Health Organisation gave the green light to Chinese manufacturer CanSinoBIO’s Covid-19 vaccine – the ninth jab to get the WHO seal of approval.
The WHO granted emergency use listing (EUL) authorisation to the single-shot Convidecia vaccine as China battles a resurgence of the virus triggered by the Omicron variant.
It is the third Chinese-made vaccine to be approved by the UN’s health agency, after Sinovac and Sinopharm.
Convidecia was found to have 64% efficacy against symptomatic disease and 92% efficacy against severe Covid-19, the WHO said.
“The vaccine meets WHO standards for protection against Covid-19 and ... the benefits of the vaccine far outweigh risks,” the UN health agency said in a statement.
The WHO’s vaccine experts recommended it for people aged 18 and above.
Convidecia may be used as a booster dose following a completed primary series using any other EUL Covid-19 vaccine, said the WHO.
The jab has already been rolled out in several countries including China, Argentina, Chile, Malaysia, Mexico and Pakistan.
By the end of 2021, more than 58 million people had already been vaccinated with the jab, including nearly 14 million in China, the WHO said.
The WHO has now given EUL status to nine Covid-19 vaccines and variations thereof – Pfizer/BioNTech, AstraZeneca, Janssen, Moderna, Sinovac, Sinopharm, Bharat Biotech, Novavax and CanSinoBIO.
Convidecia is based on a modified human adenovirus.
The AstraZeneca and Janssen vaccines are also both based on viral vector technology.
The more traditional approach uses a genetically-engineered version of the common cold adenovirus as a “vector” to shuttle genetic instructions into human cells.
Convidecia “demonstrates a favourable safety profile in people across different age groups”, eliciting strong immune responses with both binding and neutralising antibodies, said the WHO. — AFP
Four COVID-death peaks:The
COVID death toll in US reached one million last week, marking the total
failure of US anti-epidemic policies. According to statistics, there
were four peaks of daily new death cases since February 2020. How did
the US policy fail so badly?
WHO okayed vaccines including CanSinoBIO jab
Geneva: The World Health Organisation gave the green light to Chinese
manufacturer CanSinoBIO’s Covid-19 vaccine – the ninth jab to get the
WHO seal of approval.
The WHO granted emergency use listing (EUL) authorisation to the
single-shot Convidecia vaccine as China battles a resurgence of the
virus triggered by the Omicron variant.
It is the third Chinese-made vaccine to be approved by the UN’s health agency, after Sinovac and Sinopharm.
Convidecia was found to have 64% efficacy against symptomatic disease and 92% efficacy against severe Covid-19, the WHO said.
“The vaccine meets WHO standards for protection against Covid-19 and ...
the benefits of the vaccine far outweigh risks,” the UN health agency
said in a statement.
The WHO’s vaccine experts recommended it for people aged 18 and above.
Convidecia may be used as a booster dose following a completed primary
series using any other EUL Covid-19 vaccine, said the WHO.
The jab has already been rolled out in several countries including China, Argentina, Chile, Malaysia, Mexico and Pakistan.
By the end of 2021, more than 58 million people had already been
vaccinated with the jab, including nearly 14 million in China, the WHO
said.
The WHO has now given EUL status to nine Covid-19 vaccines and
variations thereof – Pfizer/BioNTech, AstraZeneca, Janssen, Moderna,
Sinovac, Sinopharm, Bharat Biotech, Novavax and CanSinoBIO.
Convidecia is based on a modified human adenovirus.
The AstraZeneca and Janssen vaccines are also both based on viral vector technology.
The more traditional approach uses a genetically-engineered version of
the common cold adenovirus as a “vector” to shuttle genetic instructions
into human cells.
Convidecia “demonstrates a favourable safety profile in people across
different age groups”, eliciting strong immune responses with both
binding and neutralising antibodies, said the WHO. — AFP
Four COVID-death peaks:The COVID death toll in US reached one million last week, marking the total failure of US anti-epidemic policies. According to statistics, there were four peaks of daily new death cases since February 2020. How did the US policy fail so badly? 
Geneva: The World Health Organisation gave the green light to Chinese manufacturer CanSinoBIO’s Covid-19 vaccine – the ninth jab to get the WHO seal of approval.
67
74
